Results 91 to 100 of about 14,546 (260)
The Evolution of Transjugular Intrahepatic Portosystemic Shunt: Tips [PDF]
ISRN Hepatology, 2014 Since Richter’s description in the literature in 1989 of the first procedure on human patients, transjugular intrahepatic portosystemic shunt (TIPS) has been worldwide considered as a noninvasive technique to manage portal hypertension complications. TIPS succeeds in lowering the hepatic sinusoidal pressure and in increasing the circulatory flow, thus ...
openaire +3 more sources
Role of TIPS in Improving Survival of Patients with Decompensated Liver Disease [PDF]
, 2011 Liver cirrhosis is associated with higher morbidity and reduced survival with appearance of portal hypertension and resultant decompensation. Portal decompression plays a key role in improving survival in these patients.
Amarapurkar, Deepak N. +1 more
core +3 more sources
Liver International, Volume 45, Issue 10, October 2025.ABSTRACT Background and Aims We aimed to ascertain the prevalence of sarcopenia in patients with primary sclerosing cholangitis (PSC) and to assess the prognostic value as a biomarker for disease outcome. Methods We collected data from 224 patients (148 male, 76 female; mean age 41 years) from January 2002 to December 2021, with a confirmed diagnosis ...
Alena Levers +8 more
wiley +1 more source
Gastrointestinal Intervention, 2018 Initial underdilation of transjugular intrahepatic portosystemic shunt (TIPS) stents has been a widely proposed and commonly practiced technique to balance portal hypertension relief and the adverse effects associated with excess shunting, especially ...
Harry Trieu, Edward Wolfgang Lee
doaj +1 more source
Spondylodiscitis associated with recurrent Serratia bacteremia due to a transjugular intrahepatic portosystemic shunt (TIPS): a case report [PDF]
, 2009 We report a case of spondylodiscitis caused by multiresistant Serratia marcescens in a cirrhotic patient who had several Serratia bacteremias after the placement of a transjugular intrahepatic portosystemic shunt (TIPS) device.
Coelho, F +4 more
core
Non-pharmacological Treatment of Ascites [PDF]
, 2017 Diuretics are considered the first-line pharmacological treatment option for ascites. Diuretic treatment begins with spironolactone and furosemide.
Abaalkhail, Faisal +4 more
core +2 more sources
Liver International, Volume 45, Issue 10, October 2025.ABSTRACT Background and Aims Alcohol‐related liver disease (ALD) is associated with elevated blood immunoglobulin‐type M (IgM) levels and hepatic lipid peroxidation. Nevertheless, the functional relevance of systemic IgM targeting lipid peroxidation products during ALD is incompletely understood.
Dragana Rajcic +17 more
wiley +1 more source
Insights into ImagingObjectives Transjugular intrahepatic portosystemic shunt (TIPS) is a catheter-based, minimally invasive procedure to reduce portal hypertension. The aim of the study was to investigate dysfunction and mortality after TIPS and to identify factors ...
Laura Büttner +11 more
doaj +1 more source
Role of manganese in the pathogenesis of portal-systemic encephalopathy
, 1998 Amongst the potential neurotoxins implicated in the pathogenesis of hepatic encephalopathy, manganese emerges as a new candidate. In patients with chronic liver diseases, manganese accumulates in blood and brain leading to pallidal signal hyperintensity ...
Butterworth, Roger +5 more
core +1 more source
Interventional treatment with the Transjugular Intrahepatic Portosystemic Shunt (TIPS) procedure may offer a preferable alternative to systemic anticoagulation in patients with cirrhosis and portal vein thrombosis [PDF]
, 2021 A clinical decision report appraising: Wang Z, Jiang MS, Zhang HL, et al. Is post-tips anticoagulation therapy necessary in patients with cirrhosis and portal vein thrombosis? A randomized controlled trial. Radiology. 2016;279(3):943-951. https://doi.org/
Pantelic, Molly N.
core +1 more source